Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Total revenues	$ 37,447	$ 35,572	$ 34,949
Total cost of revenues	(23,919)	(22,871)	(22,986)
Gross (loss) profit	13,528	12,701	11,963
Selling, general and administrative expenses	(8,283)	(7,852)	(7,486)
Gain on disposal of long-lived assets	235	237	66
Loss on impairments	(40)	(161)	(357)
Operating income	5,440	4,925	4,186
Interest income	146	143	206
Interest expense	(810)	(612)	(376)
Other nonoperating income (expense), net	29	258	(2)
Income before income tax expense and income from equity method investments	4,805	4,714	4,014
Income tax expense	(1,041)	(1,085)	(925)
Income (loss) from equity method investments	26	(108)	(17)
Income from continuing operations	3,790	3,521	3,072
Net (income) attributable to redeemable noncontrolling interests	(28)	(28)	(28)
Net (income) loss attributable to noncontrolling interests	(9)	(1)	134
Net income attributable to CRH	$ 3,753	$ 3,492	$ 3,178
Earnings per share attributable to CRH
Basic earnings per share attributable to CRH plc, net income (in USD per share)	$ 5.54	$ 5.06	$ 4.36
Diluted earnings per share, net income (in USD per share)	$ 5.51	$ 5.02	$ 4.33
Weighted average common shares outstanding
Weighted average common shares outstanding, basic (in shares)	673.2	683.3	723.9
Weighted average common shares outstanding, diluted (in shares)	677.0	689.5	729.2
Product
Total revenues	$ 28,754	$ 26,699	$ 26,156
Total cost of revenues	(15,990)	(14,651)	(14,741)
Service
Total revenues	8,693	8,873	8,793
Total cost of revenues	$ (7,929)	$ (8,220)	$ (8,245)